Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-24

FDA Approved: ACETAZOLAMIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for acetazolamide submitted by Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

SUPPL AP for ACETAZOLAMIDE (ACETAZOLAMIDE)